Altre lingue Senvest Capital Inc.

Azioni

SEC

CA81731L1094

Tempo differito Toronto S.E. Altri mercati azionari 17:20:21 29/04/2024			Variaz. 5gg	Var. 1 gen.
290 ^CAD	+1,75%		+1,75%	-6,45%

29/03	Senvest Capital Inc. riporta i risultati degli utili per l'intero anno terminato il 31 dicembre 2023	CI
2023	Senvest Capital Inc. riporta i risultati degli utili per il terzo trimestre e i nove mesi conclusi il 30 settembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

North American Morning Briefing : Focus Turns to -2-	04/04
Biolinq Incorporated announced that it has received $58 million in funding from a group of investors	04/04
Senvest Capital Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Senvest Capital Brief: Reporting net income attributable to common shareholders of $83.6 million or $33.78 per share for year ended December 31, 2023	28/03
Senvest Capital Inc annonce ses résultats pour l’année financière terminée le 31 décembre 2023	28/03
Senvest Capital Reports Results for the Year Ended December 31, 2023	28/03
Biolinq Incorporated announced that it expects to receive funding	13/12
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2022.	03/11
Tranche Update on Senvest Capital Inc.'s Equity Buyback Plan announced on August 11, 2023.	03/11
Senvest Capital Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	03/11
Senvest Capital Brief: Reported net loss attributable to common shareholders of ($67.0) million or ($27.07) per share for Q3	03/11
Senvest Capital Inc. annonce ses rėsultats pour le trimestre terminé le 30 septembre 2023	03/11
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2023	03/11
Senvest Capital Inc. Reports Results for the Third Quarter Ended September 30, 2023	03/11
Senvest Capital Inc.'s Equity Buyback announced on August 11, 2022, has expired with 13,000 shares, representing 0.52% for CAD 3.96 million.	15/08/23
Senvest Capital Obtains TSX Consent For Normal Course Issuer Bid	11/08/23
Senvest Capital Inc. announces an Equity Buyback for 100,000 shares, representing 4.04% of its issued share capital.	11/08/23
Senvest Capital Brief: Announcing Acceptance by TSX of Normal Course Issuer Bid	11/08/23
Senvest Capital Inc. annonce que la TSX a approuvé son offre publique de rachat dans le cours normal des activités	11/08/23
Senvest Capital Inc. Announces Acceptance by TSX of Normal Course Issuer Bid	11/08/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Senvest Capital Inc.

Azioni

SEC

CA81731L1094

Altre lingue

Filtri